 |
Monoclonal antibody PM-81 |
|---|---|
| Trade Name | |
| Orphan Indication | Adjunctive treatment of acute myelogenous leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1991-06-27 00:00:00 |
| Sponsor | Medarex, Inc.;519 Route 173 West;Bloomsbury, New Jersey, 08804 |
| |
Monoclonal antibody PM-81 |
|---|---|
| Trade Name | |
| Orphan Indication | Adjunctive treatment of acute myelogenous leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1991-06-27 00:00:00 |
| Sponsor | Medarex, Inc.;519 Route 173 West;Bloomsbury, New Jersey, 08804 |